Genertec Universal Medical Group Company Limited (5UM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Genertec Universal Medical Group Company Limited (5UM) has a cash flow conversion efficiency ratio of -0.085x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.67 Billion ≈ $-1.95 Billion USD) by net assets (€19.69 Billion ≈ $23.01 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 5UM stock market capitalisation for the company's overall valuation and market capitalisation.
Genertec Universal Medical Group Company Limited - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Genertec Universal Medical Group Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Genertec Universal Medical Group Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genertec Universal Medical Group Company Limited ranked by their cash flow conversion efficiency. Explore earnings quality score of Genertec Universal Medical Group Company to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Business First Bancshares Inc
NASDAQ:BFST
|
0.027x |
|
BTS Group Holdings Public Company Limited
BK:BTS
|
0.025x |
|
CSSC Offshore & Marine Engineering (Group) Co Ltd
F:GSZ
|
-0.130x |
|
Luoniushan Co Ltd
SHE:000735
|
0.012x |
|
Altri SGPS SA
LS:ALTR
|
0.074x |
|
Camelot Electronics Technology Co. Ltd. A
SHE:301282
|
N/A |
|
SFA Semicon Co. Ltd
KQ:036540
|
-0.003x |
|
EnTie Commercial Bank Ltd
TW:2849
|
0.031x |
Annual Cash Flow Conversion Efficiency for Genertec Universal Medical Group Company Limited (2016–2025)
The table below shows the annual cash flow conversion efficiency of Genertec Universal Medical Group Company Limited from 2016 to 2025. View current stock price of Genertec Universal Medical Group Company for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €25.04 Billion ≈ $29.27 Billion |
€5.78 Billion ≈ $6.75 Billion |
0.231x | +363.49% |
| 2024-12-31 | €22.87 Billion ≈ $26.74 Billion |
€1.14 Billion ≈ $1.33 Billion |
0.050x | -79.70% |
| 2023-12-31 | €20.37 Billion ≈ $23.81 Billion |
€4.99 Billion ≈ $5.84 Billion |
0.245x | +134.83% |
| 2022-12-31 | €19.70 Billion ≈ $23.03 Billion |
€2.06 Billion ≈ $2.41 Billion |
0.104x | +231.38% |
| 2021-12-31 | €17.62 Billion ≈ $20.60 Billion |
€-1.40 Billion ≈ $-1.64 Billion |
-0.079x | -22.39% |
| 2020-12-31 | €14.97 Billion ≈ $17.50 Billion |
€-971.72 Million ≈ $-1.14 Billion |
-0.065x | +52.13% |
| 2019-12-31 | €13.45 Billion ≈ $15.72 Billion |
€-1.82 Billion ≈ $-2.13 Billion |
-0.136x | +75.72% |
| 2018-12-31 | €10.26 Billion ≈ $11.99 Billion |
€-5.73 Billion ≈ $-6.70 Billion |
-0.559x | +17.76% |
| 2017-12-31 | €7.47 Billion ≈ $8.73 Billion |
€-5.07 Billion ≈ $-5.93 Billion |
-0.679x | -87.46% |
| 2016-12-31 | €6.57 Billion ≈ $7.69 Billion |
€-2.38 Billion ≈ $-2.78 Billion |
-0.362x | -- |
About Genertec Universal Medical Group Company Limited
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. Its Healthcare Business segment inc… Read more